Paratek
Developing new treatment options for complex medical issues and providing new technologies to defeat superbugs.
Launch date
Employees
Market cap
€116m
Enterprise valuation
€314m (Public information from Sep 2023)
Share price
$2.23 PRTK
Boston Massachusetts (HQ)
Financials
Estimates*
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | 12.6m | 17.1m | 16.5m | 43.5m | 121m | 151m |
| % growth | - | 36 % | (3 %) | 163 % | 178 % | 25 % |
| EBITDA | (82.0m) | (101m) | (112m) | (73.9m) | (40.7m) | (44.9m) |
| % EBITDA margin | (650 %) | (589 %) | (678 %) | (170 %) | (34 %) | (30 %) |
| Profit | (89.1m) | (112m) | (129m) | (96.5m) | (59.1m) | (63.6m) |
| % profit margin | (706 %) | (656 %) | (778 %) | (222 %) | (49 %) | (42 %) |
| R&D budget | 60.1m | 57.5m | 39.6m | 23.9m | 30.4m | 37.8m |
| R&D % of revenue | 476 % | 336 % | 239 % | 55 % | 25 % | 25 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
$40.0m | Post IPO Equity | ||
| N/A | N/A | IPO | |
N/A | Post IPO Equity | ||
$60.0m | Post IPO Debt | ||
| Total Funding | - | ||
Recent News about Paratek
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.